Friday, September 7, 2018

At the competition of this activity, the participant will be able to:

• Understanding the historical federal legislative and regulatory framework around DIR fees, and more specifically pharmacy DIR fees
•  Identifying the various types of pharmacy DIR fees and terminology for pharmacy DIR fees and other retroactive fees
• Assessing the impact of pharmacy DIR fees on plan sponsors, the government, and consumers
• Recognizing business solutions that can help a pharmacy reduce the impact of DIR fees

Kala Shankle, J.D. Director of Policy and Regulatory Affairs, National Community Pharmacists Association

UAN #: 0278-0000-18-018-L04-P

UAN #: 0278-0000-18-018-L04-T

1.0 Credit Hours; 0.1 CEU

Type: Knowledge-based

Category: General

At the competition of this activity, the participant will be able to:

• Explain why clinician burnout is a patient care and healthcare workforce problem that needs addressing
• Describe the National Academy of Medicine Clinician Well-Being and Resilience Action Collaborative
• Identify strategies to impact well-being and resilience in pharmacists, pharmacy residents, student pharmacists, and pharmacy technicians.

Janet Silvester, Pharm.D., M.B.A., FASHP Vice President of Accreditation Services, American Society of Health-System Pharmacists

UAN #: 0278-0000-18-019-L04-P

UAN #: 0278-0000-18-019-L04-T

1.5 Credit Hours; 0.15 CEU

Type: Knowledge-based

Category: General

At the competition of this activity, the participant will be able to:

• Identify information resources most useful to community pharmacists when filling prescriptions for animal patients
• Recognize the overarching principles of veterinary drug laws and regulations
• Describe the impact of species-specific vital signs, metabolic capacity, gastrointestinal physiology, and dietary habit on drug disposition in animals
• Review the most common veterinary-only drugs
• List most common dispensing errors on veterinary prescriptions

Gigi Davidson, BSPharm, DICVP, Director of Clinical Pharmacy Services, NC State of University College of Veterinary Medicine

UAN #: 0278-0000-18-016-L06-P

UAN #: 0278-0000-18-016-L06-T

1.5 Credit Hours; 0.15 CEU

Type: Knowledge-based

Category: Immunizations

At the competition of this activity, the participant will be able to:

• Identify updated 2018 recommendations for specific vaccine use
• Recognize disease risk in certain populations
• Recognize the rational for providing vaccinations in a pharmacy

UAN #: 0278-0000-18-014-L03-P

UAN #: 0278-0000-18-014-L03-T

1.5 Credit Hours; 0.15 CEU

Type: Knowledge-based

Category: Law related to Pharmacy Practice

At the competition of this activity, the participant will be able to:

• Summarize select pharmacy-related bills passed by the 2018 General Assembly
• Describe recent Board of Pharmacy action related to regulations and board guidance
• Review ongoing and upcoming projects related to pharmaceutical processors, e-prescribing, routine pharmacy inspections, and PMP-related subjects

Saturday, September 8, 2018

UAN #: 0278-0000-18-025-L04-P

UAN #: 0278-0000-18-025-L04-T

2.0 Credit Hours; 0.2 CEU

Type: Knowledge-based

Category: General

At the competition of this activity, the participant will be able to:

• Identify and explain aspects of the effective and safe practice of pharmacy self-care treatments
• Describe at least two over the counter and prescription medication interactions that pharmacists and pharmacy technicians should be aware of
• List three OTC medications and their use. Pharmacists should identify counseling points for each of three OTC medications

UAN #: 0278-0000-18-021-L04-P

UAN#: 0278-0000-18-021-L04-T

1.5 Credit Hours, 0.15 CEU

Type: Knowledge-based

Category: General

At the completion of this activity, the participant will be able to:

• Discuss the unique challenges and opportunities for pharmacists in the medical cannabis industry
• Discuss the health benefits and possible side effects for patients using medical cannabinoids for health-related conditions
• Discuss information important for Pharmacist/Patient first time consultations
• “Cannabis Pharmacist” – A day in the life
• Recognize the US states where a pharmacist mandate is required.  Describe the differences between a pharmacist run vs a non-pharmacist run medical cannabis dispensary

At the competition of this activity, the participant will be able to:

• Describe red flags associated with suspicious prescriptions
• Explain the importance of reviewing PMP reports and process for becoming a pharmacist’s delegate
• Describe how the Department of Health Professions uses PMP data to identify indiscriminate dispensing patterns
• Discuss methods to reduce internal theft or loss of drugs
• Explain the value of dispensing naloxone and different methods for how it can be dispensed

Caroline Juran, RPh, Executive Director, Virginia Board of Pharmacy

Ellen Shinaberry, Deputy Executive Director, Virginia Board of Pharmacy 

UAN #: 0278-0000-18-015-L04-P

UAN #: 0278-0000-18-015-L04-T

1.5 Credit Hours; 0.15 CEU

Type: Knowledge-based

Category: General

At the competition of this activity, the participant will be able to:

• Compare and contrast different types of dementia
• Differentiate between stages of dementia
• Evaluate the role of acetylcholinesterase inhibitors and NMDA receptor antagonists based on stage of dementia
• Analyze risks and benefits of medications used to treat sleep disturbances in dementia
• Identify different types of dementia
• List medications used to treat each stage of dementia
• Recognize sleep disturbances and medications used to treat sleep disturbances in dementia

Sunday, September 9, 2018

Sharon Gatewood, Pharm D. Virginia Commonwealth University School of Pharmacy

Dennis Stanley, RPh, Publix Pharmacy

UAN #: 0278-0000-18-017-L04-P

UAN #: 0278-0000-18-017-L04-T

2.0 Credit Hours; 0.2 CEU

Type: Knowledge-based

Category: General

At the competition of this activity, the participant will be able to:

• Identify the new drugs approved by the FDA that are most clinically relevant to general practice in 2018
• Discuss relevant indications, efficacy, pharmcokinectics, safety, and dosing of new drugs
• Discuss how the new drugs differ from existing drugs on the market
• Determine how to best incorporate the new drugs into clinical practice using a case-based format

Category: General

At the competition of this activity, the participant will be able to:

• Understand what Chronic Care Management (CCM) services are and how pharmacists can play a role in the service
• Explain the strategy options and steps for collaborating and implementing a CCM program utilizing the Implementation Guide
• Provide engaging examples of successful trials utilizing a collaborative trial between a primary provider and community pharmacist.

Cynthia L. W. Warriner, BS, RPh, CDE, Pharmacist Consultant-Health Quality Innovators

UAN #: 0278-0000-18-022-L04-P

UAN #: 0278-0000-18-022-L04-T

1.0 Credit Hours; 0.1 CEU

Type: Knowledge-based

Category: General

At the competition of this activity, the participant will be able to:

• Describe the current biosimilar marketplace and how it compared with the generic drug uptake in the United States.
• Explain the limitations of clinical trial data in supporting real world clinical and economic decision making.
• Describe what post-marketing data are needed to assess biosimilar safety and efficacy and initiatives that have been created to study these issues.

Category: General

At the competition of this activity, the participant will be able to:

• What are the “Big Three” affecting a pharmacy’s P & L
• How to effectively manage “The Big Three”
• Ways to Maximize Reimbursement.

Scott Podolan, RPh
Pharmacy Business Coach-AmerisourceBergen

UAN #: 0278-0000-18-020-L04-P

UAN #: 0278-0000-18-020-L04-T

1.0 Credit Hours; 0.10 CEU

Type: Knowledge-based

Category: General

At the competition of this activity, the participant will be able to:

• Identify a set of interactive questions to discuss with a patient to assist in determining if they are considering self-harm
• Develop the confidence to continue an interactive discussion if the patient is deemed to be at risk of suicide
• Understand a menu of options to discuss with patients regarding dealing effectively with suicidal thoughts, including connecting with mental health professionals.